These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 35104168)

  • 41. Early engineering approaches to improve peptide developability and manufacturability.
    Furman JL; Chiu M; Hunter MJ
    AAPS J; 2015 Jan; 17(1):111-20. PubMed ID: 25338742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Developability studies before initiation of process development: improving manufacturability of monoclonal antibodies.
    Yang X; Xu W; Dukleska S; Benchaar S; Mengisen S; Antochshuk V; Cheung J; Mann L; Babadjanova Z; Rowand J; Gunawan R; McCampbell A; Beaumont M; Meininger D; Richardson D; Ambrogelly A
    MAbs; 2013; 5(5):787-94. PubMed ID: 23883920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Developability assessment in pharmaceutical industry: An integrated group approach for selecting developable candidates.
    Saxena V; Panicucci R; Joshi Y; Garad S
    J Pharm Sci; 2009 Jun; 98(6):1962-79. PubMed ID: 18855914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland.
    Beck A; Wurch T; Reichert JM
    MAbs; 2011; 3(2):111-32. PubMed ID: 21441785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel screening method to assess developability of antibody-like molecules.
    Kohli N; Jain N; Geddie ML; Razlog M; Xu L; Lugovskoy AA
    MAbs; 2015; 7(4):752-8. PubMed ID: 25961854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Developability assessment].
    Dumas J; Huille S; Prades C
    Med Sci (Paris); 2019 Dec; 35(12):1163-1170. PubMed ID: 31903932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Machine Learning for Biologics: Opportunities for Protein Engineering, Developability, and Formulation.
    Narayanan H; Dingfelder F; Butté A; Lorenzen N; Sokolov M; Arosio P
    Trends Pharmacol Sci; 2021 Mar; 42(3):151-165. PubMed ID: 33500170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rational optimization of a monoclonal antibody improves the aggregation propensity and enhances the CMC properties along the entire pharmaceutical process chain.
    Bauer J; Mathias S; Kube S; Otte K; Garidel P; Gamer M; Blech M; Fischer S; Karow-Zwick AR
    MAbs; 2020; 12(1):1787121. PubMed ID: 32658605
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toward enhancement of antibody thermostability and affinity by computational design in the absence of antigen.
    Hutchinson M; Ruffolo JA; Haskins N; Iannotti M; Vozza G; Pham T; Mehzabeen N; Shandilya H; Rickert K; Croasdale-Wood R; Damschroder M; Fu Y; Dippel A; Gray JJ; Kaplan G
    MAbs; 2024; 16(1):2362775. PubMed ID: 38899735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early determination of potential critical quality attributes of therapeutic antibodies in developability studies through surface plasmon resonance-based relative binding activity assessment.
    Wang S; Wang Y; Li Z; Hong Y; Wang Z; Fan J; Wang Q; Ge Y; Zhao X; Cheng G; Chen C; Wu Y; Fu Y
    MAbs; 2024; 16(1):2374607. PubMed ID: 38956880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.
    Bak A; Leung D; Barrett SE; Forster S; Minnihan EC; Leithead AW; Cunningham J; Toussaint N; Crocker LS
    AAPS J; 2015 Jan; 17(1):144-55. PubMed ID: 25398427
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulatory Approved Monoclonal Antibodies Contain Framework Mutations Predicted From Human Antibody Repertoires.
    Petersen BM; Ulmer SA; Rhodes ER; Gutierrez-Gonzalez MF; Dekosky BJ; Sprenger KG; Whitehead TA
    Front Immunol; 2021; 12():728694. PubMed ID: 34646268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimization of therapeutic antibodies.
    Wang B; Gallolu Kankanamalage S; Dong J; Liu Y
    Antib Ther; 2021 Jan; 4(1):45-54. PubMed ID: 33928235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Developability index: a rapid in silico tool for the screening of antibody aggregation propensity.
    Lauer TM; Agrawal NJ; Chennamsetty N; Egodage K; Helk B; Trout BL
    J Pharm Sci; 2012 Jan; 101(1):102-15. PubMed ID: 21935950
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analytical Workflows to Unlock Predictive Power in Biotherapeutic Developability.
    Trikeriotis M; Akbulatov S; Esposito U; Anastasiou A; Leszczyszyn OI
    Pharm Res; 2023 Feb; 40(2):487-500. PubMed ID: 36471025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions.
    Tomar DS; Li L; Broulidakis MP; Luksha NG; Burns CT; Singh SK; Kumar S
    MAbs; 2017 Apr; 9(3):476-489. PubMed ID: 28125318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibody Conjugates-Recent Advances and Future Innovations.
    Leung D; Wurst JM; Liu T; Martinez RM; Datta-Mannan A; Feng Y
    Antibodies (Basel); 2020 Jan; 9(1):. PubMed ID: 31936270
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Automated Antibody De Novo Sequencing and Its Utility in Biopharmaceutical Discovery.
    Sen KI; Tang WH; Nayak S; Kil YJ; Bern M; Ozoglu B; Ueberheide B; Davis D; Becker C
    J Am Soc Mass Spectrom; 2017 May; 28(5):803-810. PubMed ID: 28105549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deamidation and isomerization liability analysis of 131 clinical-stage antibodies.
    Lu X; Nobrega RP; Lynaugh H; Jain T; Barlow K; Boland T; Sivasubramanian A; Vásquez M; Xu Y
    MAbs; 2019 Jan; 11(1):45-57. PubMed ID: 30526254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Agonist antibody discovery: Experimental, computational, and rational engineering approaches.
    Schardt JS; Jhajj HS; O'Meara RL; Lwo TS; Smith MD; Tessier PM
    Drug Discov Today; 2022 Jan; 27(1):31-48. PubMed ID: 34571277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.